Tumor-infiltrating CD8+ T cells were more activated (as reflected by the proportion of PD-1+TIM-3+ CD8+ T cells) and exhibited enhanced cytotoxicity (as reflected by Granzyme B and IFNγ levels) (Fig. 4b, e). The gene discussed is CD8A; the disease is neoplasm.